FrancophonIA/ELRC3.0 huggingface dataset:
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Abseamed dose by about 25 to 50%.
Slovenian: Če se koncentracija hemoglobina zveča za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če raven koncentracije hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Abseamed za približno 25 do 50 %.
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Abseamed should be stopped and further dosages should not be administered.
Slovenian: Če v obdobju pred kirurškim posegom raven hemoglobina doseže 15 g/dl (9,38 mmol/l) ali več, je treba zdravljenje z zdravilom Abseamed prekiniti.
English: Only take one dose of Abseamed from each syringe.
Slovenian: Uporabite le en odmerek zdravila Abseamed iz vsake injekcijske brizge.
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Abseamed dose by 25%.
Slovenian: Če se hemoglobin zviša za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če stalna vrednost hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Abseamed za 25 %.
English: “Instructions on how to inject Abseamed yourself” can be found at the end of the package leaflet.
Slovenian: „Navodila za samoinjiciranje zdravila Abseamed“ lahko najdemo na koncu navodila za uporabo.
English: Only take one dose of Abseamed from each syringe discarding unwanted solution before injection.
Slovenian: Iz vsake brizge odvzemite samo en odmerek zdravila Abseamed in pred injiciranjem zavrzite preostalo raztopino.
English: Abseamed should be administered by the intravenous route.
Slovenian: Zdravilo Abseamed je treba dati intravensko.
English: What Abseamed contains
Slovenian: Kaj vsebuje navodilo
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Abseamed therapy at a dose 25% below the previous dose.
Slovenian: Če hemoglobin preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje nadaljevati z zdravilom Abseamed z odmerkom, ki je 25 % manjši od prejšnjega odmerka.
English: Epoetin alfa has been shown to stimulate erythropoiesis in anaemic patients with CRF, including dialysis and pre-dialysis patients.
Slovenian: Kronična ledvična odpoved Pokazalo se je, da epoetin alfa spodbuja eritropoezo pri anemičnih bolnikih s kronično ledvično odpovedjo, vključno z bolniki, ki se zdravijo z dializo, in s tistimi, ki se z dializo še ne zdravijo.
English: INFORMATION IN BRAILLE Abseamed 8,000 IU/0.8 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 8.000 i.e./0,8 ml
English: If you are a cancer patient be aware that products that stimulate red blood cell production (like Abseamed) may act as a growth factor and therefore in theory may affect the progression of your cancer.
Slovenian: (kot je zdravilo Abseamed), delujejo kot rastni faktor in s tem teoretično vplivajo na napredovanje raka.
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Abseamed therapy at a dose 25% below the previous dose.
Slovenian: Če raven koncentracije hemoglobina preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje z zdravilom Abseamed začeti znova z odmerkom, ki je za približno 25 % manjši od predhodnega.
English: Abseamed should not be used:
Slovenian: zdravila Abseamed ne smete uporabljati.
English: INFORMATION IN BRAILLE Abseamed 7,000 IU/0.7 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 7.000 i.e./0,7 ml
English: - All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Abseamed.
Slovenian: - Pri bolnikih, ki dobivajo zdravilo Abseamed, je treba upoštevati vse kontraindikacije, povezane s preddonorskimi programi avtolognega zbiranja krvi.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Slovenian: Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,8 ml raztopine za injiciranje.
English: Abseamed is provided with or without a needle safety guard and you will be shown how to use this by your doctor or nurse.
Slovenian: vaš zdravnik ali medicinska sestra pa vam bosta pokazala, kako to uporabljati.
English: INFORMATION IN BRAILLE Abseamed 30,000 IU/0.75 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 30.000 i.e./0,75 ml
English: INFORMATION IN BRAILLE Abseamed 9,000 IU/0.9 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 9.000 i.e./0,9 ml
English: INFORMATION IN BRAILLE Abseamed 40,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 40.000 i.e./1 ml
English: INFORMATION IN BRAILLE Abseamed 6,000 IU/0.6 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 6.000 i.e./0,6 ml
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: How to store Abseamed
Slovenian: Shranjevanje zdravila Abseamed
English: INFORMATION IN BRAILLE Abseamed 4,000 IU/0.4 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 4.000 i.e./0,4 ml
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Slovenian: Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,75 ml raztopine za injiciranje.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/013
Slovenian: Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/013
English: INFORMATION IN BRAILLE Abseamed 20,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 20.000 i.e./0,5 ml
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Slovenian: Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,7 ml raztopine za injiciranje.
English: - in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis (see section 4.4).
Slovenian: Zdravilo Abseamed je indicirano za zdravljenje simptomatske anemije, povezane s kronično ledvično odpovedjo: - pri odraslih in otrocih, starih 1 do 18 let, ki se zdravijo s hemodializo, in odraslih bolnikih, ki se zdravijo s peritonealno dializo (glejte poglavje 4.4).
English: Rare side effects These may affect up to 1 in 1,000 people.
Slovenian: Pojavijo se lahko pri največ 1 od 1.000 bolnikov
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 9,000 IU/0.9 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 9.000 i.e./0,9 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Slovenian: Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,9 ml raztopine za injiciranje.
English: Pre-filled syringe with needle safety guard
Slovenian: Napolnjena injekcijska brizga z varnostno zaščito za iglo
English: INFORMATION IN BRAILLE Abseamed 5,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 5.000 i.e./0,5 ml
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Slovenian: Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 40.000 mednarodnih enot (i.e.), kar ustreza 336,0 mikrogramov epoetina alfa.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Slovenian: Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 2.000 i.e. epoetina alfa*, kar ustreza 16,8 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 2.000 mednarodnih enot (i.e.), kar ustreza 16,8 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 7,000 IU/0.7 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 7.000 i.e./0,7 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Slovenian: Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,4 ml raztopine za injiciranje.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 8,000 IU/0.8 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 8.000 i.e./0,8 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Slovenian: Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,6 ml raztopine za injiciranje.
English: INFORMATION IN BRAILLE Abseamed 2,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 2.000 i.e./1 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 30,000 IU/0.75 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 30.000 i.e./0,75 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023
Slovenian: Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/023
English: IV/SC
Slovenian: < 1 g/dl
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Slovenian: Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021
Slovenian: Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/021
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 4,000 IU/0.4 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 4.000 i.e./0,4 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Slovenian: Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,3 ml raztopine za injiciranje.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/011
Slovenian: Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/011
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/412/019
Slovenian: Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/019
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Slovenian: Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/412/017
Slovenian: Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/017
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 6,000 IU/0.6 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 6.000 i.e./0,6 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL).
Slovenian: ≤ 10 g/dl) pri odraslih s primarnimi mielodisplastičnimi sindromi (MDS) z nizkim ali srednjim-1
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: INFORMATION IN BRAILLE Abseamed 10,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 10.000 i.e./1 ml
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,5 ml napolnjena injekcijska brizga vsebuje 5.000 mednarodnih enot (i.e.), kar ustreza 42,0 mikrogramov epoetina alfa.
English: INFORMATION IN BRAILLE Abseamed 3,000 IU/0.3 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 3.000 i.e./0,3 ml
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/412/007
Slovenian: Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/007
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/025
Slovenian: Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/025
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/009
Slovenian: Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/009
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/003
Slovenian: Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/003
English: Abseamed should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Slovenian: Zdravilo Abseamed se daje z namenom zvišati hemoglobin na raven do 12 g/dl (7,5 mmol/l).
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/412/005
Slovenian: Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/005
English: Do not shake Abseamed syringes.
Slovenian: Injekcijskih brizg z zdravilom Abseamed ne stresajte.
English: INFORMATION IN BRAILLE Abseamed 1,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Abseamed 1.000 i.e./0,5 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 5,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 5.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Slovenian: Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Epoetin alfa
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Slovenian: Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 0,75 ml napolnjena injekcijska brizga vsebuje 30.000 mednarodnih enot (i.e.), kar ustreza 252,0 mikrogramov epoetina alfa.
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 3,000 IU/0.3 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 3.000 i.e./0,3 ml injekcija epoetin alfa i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 40,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 40.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/015
Slovenian: Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/015
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,7 ml napolnjena injekcijska brizga vsebuje 7.000 mednarodnih enot (i.e.), kar ustreza 58,8 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 20,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 20.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 10.000 mednarodnih enot (i.e.), kar ustreza 84,0 mikrogramov epoetina alfa.
English: • breathlessness.
Slovenian: • zasoplost.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Epoetin alfa
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/001
Slovenian: Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/001
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Slovenian: Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 2.000 i.e. epoetina alfa*, kar ustreza 16,8 mikrogramov na ml. 0,5 ml napolnjena injekcijska brizga vsebuje 1.000 mednarodnih enot (i.e.), kar ustreza 8,4 mikrogramov epoetina alfa.
English: Abseamed should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Slovenian: Bolnikom z anemijo (npr. s koncentracijo hemoglobina ≤ 10 g/dl (6,2 mmol/l)) je treba zdravilo
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Epoetin alfa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 2,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 2.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: Talk to your doctor, pharmacist or nurse before using Abseamed.
Slovenian: Pred začetkom uporabe zdravila Abseamed se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,8 ml napolnjena injekcijska brizga vsebuje 8.000 mednarodnih enot (i.e.), kar ustreza 67,2 mikrogramov epoetina alfa.
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,4 ml napolnjena injekcijska brizga vsebuje 4.000 mednarodnih enot (i.e.), kar ustreza 33,6 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 10,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 10.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 1,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Abseamed 1.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Epoetin alfa
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,9 ml napolnjena injekcijska brizga vsebuje 9.000 mednarodnih enot (i.e.), kar ustreza 75,6 mikrogramov epoetina alfa.
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable.
Slovenian: Pri pediatričnih bolnikih s kronično ledvično odpovedjo, kjer je rutinsko na voljo intravenski dostop